Nimustine, a key chemotherapeutic agent, has shown promise in glioblastoma management. This high-grade brain tumor remains a challenge. Treatment options often fall short, but nimustine’s alkylating properties offer hope. Glioblastoma’s aggressive nature requires effective interventions. Patients face limited survival. Nimustine’s…